Market Insights Health Hospitals Inpatient Care

Midwifery - Caribbean

Caribbean

In the Caribbean, the Midwifery market is expected to experience significant growth in the coming years.
By 2024, the projected revenue is estimated to reach US$0.42bn.
This growth is anticipated to continue at an annual growth rate of 1.84% from 2024 to 2029, resulting in a market volume of US$0.46bn by the end of 2029.
When comparing this market segment globally, it is worth noting that in the United States will generate the highest revenue in the Midwifery market.
In 2024, the projected revenue for the United States is expected to reach a staggering US$34,040.00m.
This highlights the significant role in the United States plays in this market.
Midwifery in the Caribbean is experiencing a resurgence, with a growing demand for holistic and culturally-sensitive care.

Key regions: France, Europe, Japan, Germany, United Kingdom

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.